Filter
194
Filtered Results: 194
Text search:
National
Pharmacovigilance
and
Medicines
Information
Center
Featured
Recommendations
25
New Publications
59
Language
Document type
No document type
109
Guidelines
30
Studies & Reports
29
Manuals
11
Strategic & Response Plan
7
Training Material
3
Situation Updates
3
Fact sheets
2
Countries / Regions
Rwanda
10
Nigeria
10
Kenya
9
Ethiopia
9
Namibia
8
India
8
Ghana
7
South Africa
6
Nepal
5
Cambodia
5
Liberia
5
Philippines
4
Latin America and the Carribbean
4
Tanzania
4
Eastern Europe
4
Zambia
4
Mozambique
3
Western and Central Europe
3
Russia
3
Ukraine
2
Sierra Leone
2
Malawi
2
Africa
2
Asia
2
West and Central Africa
2
South–East Asia Region
2
Bangladesh
2
Uganda
2
Botswana
2
Indonesia
2
Pakistan
2
Thailand
1
Lesotho
1
Gambia
1
Cameroon
1
Laos
1
Senegal
1
Afghanistan
1
Zimbabwe
1
Haiti
1
Jordan
1
Middle East and North Africa
1
Western Pacific Region
1
East and Southern Africa
1
Argentina
1
Sri Lanka
1
Georgia
1
Libya
1
Bhutan
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
34
Policies & Guidelines HIV & TB
28
Policies
26
Guidelines
17
Studies & Reports
9
NTDs & Others
6
TB
5
Statistics
4
Pharmacy & Technology
3
Communicable Diseases
2
Vaccine-preventable Diseases
2
Pharmaceutical Assessments
2
NCD
2
Women & Child Health
2
Capacity Building
2
General Guidelines
2
Leprosy
2
Helminthiasis
1
Trachoma
1
Taeniasis/ Cysticercosis
1
Onchocerciasis
1
Schistosomiasis
1
Dermatology
1
Lymphaticfilariasis
1
Cancer
1
COVID-19
1
Pediatric cancer
1
Snakebites
1
Pediatrics
1
Countries
1
Medical Devices & Equipment
1
Clinical Guidelines
1
Respiratory Infections
1
Immunization
1
Health Systems
1
Primary Health Care
1
Non-communicable Diseases
1
Malaria
1
Disease Prevention & Control
1
Key Resources
1
Toolboxes
Country specific
7
Rational use of Medicine
7
Immunization Guidelines
6
Clinical Guidelines
5
Supporting tools
4
Hospital Readiness/Essential Health Services
4
Traditional & Herbal Medicines
4
Pharmacovigilance
4
Clinical Aspects, Treatment & Prevention
3
Country Specific
3
Pharmacy Practice
3
General Guidelines for Rational Use
3
Drug resistant TB
3
Antiretroviral Treatment ART
3
Treatment & Prevention
2
Adults
2
Ethiopia
2
Studies
2
General
2
Infection Control General
2
Access & Strategy
2
Essential Medicines
2
Falsified & Substandard
2
Pharmaceutical Assessments
2
Reports & Studies
2
Eastern Europe & Central Asia
2
Kenya
2
Reports & Studies
2
SEAR (South-east Asia Region)
2
Eastern Europe and central Asia
2
Clinical Guidelines
1
Clinical Aspects
1
Prevention & Control
1
Vaccination
1
Children & Adolescents
1
WPRO (Western Pacific Region)
1
Influenza
1
Namibia
1
HIV
1
Rwanda
1
TB & Other Vulnerable Populations
1
Children
1
Georgia
1
Drug resistance
1
Country Guidelines
1
International
1
Prevention & Preparedness
1
Context & Facts, Travel Advice
1
Surveillance & Contact tracing
1
Training, others
1
Gender Aspects
1
Oxygen Therapy
1
TB/HIV
1
Logistics & Supply
1
Fair Allocation & Ethical Aspects
1
COVAX Initiative
1
Biontech/Pfizer Comirnaty
1
Research & Pipeline
1
General documents One Health
1
Antimicrobial Resistance (AMR)
1
Non-communicable Diseases NCD
1
Heat
1
Capacity Building & Resources
1
Studies & Reports
1
Patient Safety
1
Overview, Studies & Reports
1
Clinical Aspects & Diagnosis
1
Diagnosis
1
Romania
1
Asia and Pacific
1
Co-Morbidities (except TB)
1
General Aspects
1
Regional Reports & Guidelines, others
1
Education of students & professionals
1
Research & Access
1
General Public
1
Clinical Guidelines
1
HIV service delivery
1
AmR (Region of Americas)
1
TB
1
Preparedness & Prevention
1
Treatment & Clinical Management
1
Supplement Article
www.jaids.com J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infec...
Advances have been made through expanded interventions delivered through five public health approaches: innovative and intensified disease management; preventive chemotherapy; vector ecology and management; veterinary public health services; and the provision of safe water, sanitation and hygiene. I...
Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy Plan (HSSP)-2 mentions growing antibiotic resistanceas a public health challenge.
This document provides a decision-making framework for implementation of mass treatment interventions, active case-finding campaigns and population-based surveys for neglected tropical diseases in the context of the COVID-19 pandemic. A two-step approach is proposed: a risk–benefit assessment, to ...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn...
Against this background of nearly 20 years of experience of research, development and
improvement in patient safety, the role of incident and adverse event reporting, as well as the
benefits that derive from it, is still a work in progress.This document has two main purposes:
• to provide an up...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
